Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Radiation Fibrosis Syndrome 2Pancreatic Neoplasms 2Pancreatic Adenocarcinoma 2Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Pancreatic Ductal Adenocarcinoma 1Osteosarcoma 1Neuroma, Acoustic 1Inflammation 1Fibrosis 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Camurati-Engelmann Syndrome 1

Interventions

Magnetic Resonance Spectroscopy 3Blood Specimen Collection 3Specimen Handling 2Simvastatin 2Liver Transplantation 2tremelimumab 1sofosbuvir-velpatasvir drug combination 1epigallocatechin gallate 1durvalumab 1atezolizumab 1apixaban 1User-Centered Design 1Tocopherols 1Surveys and Questionnaires 1Standard of Care 1Sodium Chloride 1Sampling Studies 1Radiotherapy 1Radiation 1Pravastatin 1Phlebotomy 1Pharmaceutical Preparations 1Pentoxifylline 1Patient Navigation 1Neuropsychological Tests 1Musculoskeletal Manipulations 1Memantine 1Losartan 1Ketoprofen 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosis × Losartan × 1 year × Clear all
NCT05637216 2026-04-24

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

Shaw Cancer Center

Phase 2 Recruiting
43 enrolled
Breast

Radiation Fibrosis Syndrome, Breast Neoplasms, Camurati-Engelmann Syndrome, Fibrosis, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡